|
1
|
Wiltshire JJ, Drake TM, Uttley L and
Balasubramanian SP: Systematic review of trends in the incidence
rates of thyroid cancer. Thyroid. 26:1541–1552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stonell R, Bannister P and Memon A:
Changing epidemiology and trends in incidence of thyroid cancer in
England, 1985–2019. Eur J Public Health. 32 (Suppl 3):ckac130.053.
2022. View Article : Google Scholar
|
|
3
|
Yao F, Yang Z, Li Y, Chen W, Wu T, Peng J,
Jiao Z and Yang A: Real-world evidence on the sensitivity of
preoperative ultrasound in evaluating central lymph node metastasis
of papillary thyroid carcinoma. Front Endocrinol (Lausanne).
13:8659112022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H: Interpretation of surgical update
in 2018 Japanese clinical practice guidelines for thyroid tumors.
Chin J Pract Surg. 39:52019.
|
|
5
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Filetti S, Durante C, Hartl D, Leboulleux
S, Locati LD, Newbold K, Papotti MG and Berruti A; ESMO Guidelines
Committee. Electronic address, : simpleclinicalguidelines@esmo.org:
Thyroid cancer: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up†. Ann Oncol. 30:1856–1883. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han L and Xu H: China anti-cancer
association guidelines for holistic integrative management of
thyroid cancer (2022 abridged version). Chin J Clin Oncol.
50:325–330. 2023.
|
|
8
|
Haddad RI, Bischoff L, Ball D, Bernet V,
Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, et
al: Thyroid carcinoma, version 2.2022, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 20:925–951. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao W, You L, Hou X, Chen S, Ren X, Chen
G and Zhao Y: The effect of prophylactic central neck dissection on
locoregional recurrence in papillary thyroid cancer after total
thyroidectomy: A systematic review and meta-analysis: pCND for the
locoregional recurrence of papillary thyroid cancer. Ann Surg
Oncol. 24:2189–2198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeh MW, Bauer AJ, Bernet VA, Ferris RL,
Loevner LA, Mandel SJ, Orloff LA, Randolph GW and Steward DL;
American Thyroid Association Surgical Affairs Committee Writing
Task Force, : American thyroid association statement on
preoperative imaging for thyroid cancer surgery. Thyroid. 25:3–14.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao H and Li H: Meta-analysis of
ultrasound for cervical lymph nodes in papillary thyroid cancer:
Diagnosis of central and lateral compartment nodal metastases. Eur
J Radiol. 112:14–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai Q, Tao Y, Liu D, Zhao C, Sui D, Xu J,
Shi T, Leng X and Lu M: Ultrasound radiomics models based on
multimodal imaging feature fusion of papillary thyroid carcinoma
for predicting central lymph node metastasis. Front Oncol.
13:12610802023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seo YL, Yoon DY, Lim KJ, Cha JH, Yun EJ,
Choi CS and Bae SH: Locally advanced thyroid cancer: Can CT help in
prediction of extrathyroidal invasion to adjacent structures? AJR
Am J Roentgenol. 195:W240–W244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zou Y, Zhang H, Li W, Guo Y, Sun F, Shi Y,
Gong Y, Lu X, Wang W and Xia S: Prediction of ipsilateral lateral
cervical lymph node metastasis in papillary thyroid carcinoma: A
combined dual-energy CT and thyroid function indicators study. BMC
Cancer. 21:2212021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Attia AS, Hussein M, Issa PP, Elnahla A,
Farhoud A, Magazine BM, Youssef MR, Aboueisha M, Shama M, Toraih E
and Kandil E: Association of BRAFV600E mutation with the
aggressive behavior of papillary thyroid microcarcinoma: A
meta-analysis of 33 studies. Int J Mol Sci. 23:156262022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parvathareddy SK, Siraj AK, Ahmed SO,
DeVera F, Al-Sobhi SS, Al-Dayel F and Al-Kuraya KS: Risk factors
for central lymph node metastases and benefit of prophylactic
central lymph node dissection in middle eastern patients with cN0
papillary thyroid carcinoma. Front Oncol. 11:8198242022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hlozek J, Pekova B, Rotnágl J, Holý R and
Astl J: Genetic changes in thyroid cancers and the importance of
their preoperative detection in relation to the general treatment
and determination of the extent of surgical intervention-A review.
Biomedicines. 10:15152022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li N, Du XL, Reitzel LR, Xu L and Sturgis
EM: Impact of enhanced detection on the increase in thyroid cancer
incidence in the United States: Review of incidence trends by
socioeconomic status within the surveillance, epidemiology, and end
results registry, 1980–2008. Thyroid. 23:103–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park CH, Song CM, Ji YB, Pyo JY, Yi KJ,
Song YS, Park YW and Tae K: Significance of the extracapsular
spread of metastatic lymph nodes in papillary thyroid carcinoma.
Clin Exp Otorhinolaryngol. 8:289–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao L, Wang J, Jiang Y, Gao Q, Wang Y, Xi
X and Zhang B: The number of central lymph nodes on preoperative
ultrasound predicts central neck lymph node metastasis in papillary
thyroid carcinoma: A prospective cohort study. Int J Endocrinol.
2020:26986592020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ywata de Carvalho A, Chulam TC and
Kowalski LP: Long-term results of observation vs prophylactic
selective level VI neck dissection for papillary thyroid carcinoma
at a cancer center. JAMA Otolaryngol Head Neck Surg. 141:599–606.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Han Y, Min Y, Chen C, Chen J,
Xiang K, Liao J, Feng Y, Hu D and Yin G: Prophylactic central neck
dissection for cN0 papillary thyroid carcinoma: Is there any
difference between western countries and China? A systematic review
and meta-analysis. Front Endocrinol (Lausanne). 14:11765122023.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pereira JA, Jimeno J, Miquel J, Iglesias
M, Munné A, Sancho JJ and Sitges-Serra A: Nodal yield, morbidity,
and recurrence after central neck dissection for papillary thyroid
carcinoma. Surgery. 138:1095–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu LS, Liang J, Li JH, Liu X, Jiang L,
Long JX, Jiang YM and Wei ZX: The incidence and risk factors for
central lymph node metastasis in cN0 papillary thyroid
microcarcinoma: A meta-analysis. Eur Arch Otorhinolaryngol.
274:1327–1338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Enomoto K, Uchino S, Watanabe S, Enomoto Y
and Noguchi S: Recurrent laryngeal nerve palsy during surgery for
benign thyroid diseases: Risk factors and outcome analysis.
Surgery. 155:522–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghaznavi SA, Ganly I, Shaha AR, English C,
Wills J and Tuttle RM: Using the American thyroid association
risk-stratification system to refine and individualize the American
joint committee on cancer eighth edition disease-specific survival
estimates in differentiated thyroid cancer. Thyroid. 28:1293–1300.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ji J and Shi X: Gene mutations as
predictors of central lymph mode metastasis in cN0 PTC: A
meta-analysis. Clin Genet. 105:130–139. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khan H, Ullah H and Nabavi SM: Mechanistic
insights of hepatoprotective effects of curcumin: Therapeutic
updates and future prospects. Food Chem Toxicol. 124:182–191. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahn BH, Kim JR, Jeong HC, Lee JS, Chang ES
and Kim YH: Predictive factors of central lymph node metastasis in
papillary thyroid carcinoma. Ann Surg Treat Res. 88:63–68. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan H, Zhou X, Jin H, Zheng M, Ming X,
Wang R and Liu J: A study on central lymph node metastasis in 543
cN0 papillary thyroid carcinoma patients. Int J Endocrinol.
2016:18781942016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi EK, Chong A, Ha JM, Jung CK O, JH and
Kim SH: Clinicopathological characteristics including BRAF V600E
mutation status and PET/CT findings in papillary thyroid carcinoma.
Clin Endocrinol (Oxf). 87:73–79. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lasolle H, Schiavo A, Tourneur A, Gillotay
P, de Faria da Fonseca B, Ceolin L, Monestier O, Aganahi B,
Chomette L, Kizys MML, et al: Dual targeting of MAPK and PI3K
pathways unlocks redifferentiation of Braf-mutated thyroid cancer
organoids. Oncogene. 43:155–170. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song Y, Xu G, Ma T, Zhu Y, Yu H, Yu W, Wei
W, Wang T and Zhang B: Utility of a multigene testing for
preoperative evaluation of indeterminate thyroid nodules: A
prospective blinded single center study in China. Cancer Med.
9:8397–8405. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang K, Wang H, Liang Z, Liang J, Li F and
Lin Y: BRAFV600E mutation associated with non-radioiodine-avid
status in distant metastatic papillary thyroid carcinoma. Clin Nucl
Med. 39:675–679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng W, Liu R, Zhu G, Wang H and Xing M:
Robust thyroid gene expression and radioiodine uptake induced by
simultaneous suppression of BRAF V600E and histone deacetylase in
thyroid cancer cells. J Clin Endocrinol Metab. 101:962–971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xing M, Alzahrani AS, Carson KA, Shong YK,
Kim TY, Viola D, Elisei R, Bendlová B, Yip L, Mian C, et al:
Association between BRAF V600E mutation and recurrence of papillary
thyroid cancer. J Clin Oncol. 33:42–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xing M, Alzahrani AS, Carson KA, Viola D,
Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, et al:
Association between BRAF V600E mutation and mortality in patients
with papillary thyroid cancer. JAMA. 309:1493–1501. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boufraqech M, Patel D, Nilubol N, Powers
A, King T, Shell J, Lack J, Zhang L, Gara SK, Gunda V, et al: Lysyl
oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer
aggressiveness. Thyroid. 29:79–92. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jolly LA, Novitskiy S, Owens P, Massoll N,
Cheng N, Fang W, Moses HL and Franco AT: Fibroblast-mediated
collagen remodeling within the tumor microenvironment facilitates
progression of thyroid cancers driven by BrafV600E and Pten loss.
Cancer Res. 76:1804–1813. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu H, Sun X, Dong B, Zhang J, Zhang J, Gu
Y, Chen L, Pang X, Ye J, Wang X and Rong Z: Systematic
characterisation and analysis of lysyl oxidase family members as
drivers of tumour progression and multiple drug resistance. J Cell
Mol Med. 29:e705362025. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oler G, Camacho CP, Hojaij FC, Michaluart
P Jr, Riggins GJ and Cerutti JM: Gene expression profiling of
papillary thyroid carcinoma identifies transcripts correlated with
BRAF mutational status and lymph node metastasis. Clin Cancer Res.
14:4735–4742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He
Y, Lun Y and Zhang J: Immune cell confrontation in the papillary
thyroid carcinoma microenvironment. Front Endocrinol (Lausanne).
11:5706042020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ferrari SM, Fallahi P, Galdiero MR,
Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V,
Varricchi G, et al: Immune and inflammatory cells in thyroid cancer
microenvironment. Int J Mol Sci. 20:44132019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kurachi M: CD8+ T cell
exhaustion. Semin Immunopathol. 41:327–337. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zander AD, Erbe R, Liu Y, Jin A, Hyun SW,
Mukhopadhyay S, Terdich B, Rosasco MG, Patel N, Mahon BM, et al:
Development and validation of the immune profile score (IPS), a
novel multiomic algorithmic assay for stratifying outcomes in a
real-world cohort of patients with advanced solid cancer treated
with immune checkpoint inhibitors. J Immunother Cancer.
13:e0113632025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fu G, Chazen RS, MacMillan C and Witterick
IJ: Development of a molecular assay for detection and
quantification of the BRAF variation in residual tissue from
thyroid nodule fine-needle aspiration biopsy specimens. JAMA Netw
Open. 4:e21272432021. View Article : Google Scholar : PubMed/NCBI
|
